Technetium 99m Market Overview
Technetium-99m (Tc-99m) is the most widely used radioisotope in diagnostic nuclear medicine, accounting for nearly 80% of all nuclear imaging procedures worldwide. Its favorable physical properties, such as a short half-life of about six hours and the emission of gamma rays detectable by gamma cameras, make it ideal for imaging various organs, including the heart, brain, bones, and kidneys. The growing prevalence of cardiovascular disorders, cancer, and neurological diseases is driving the demand for nuclear imaging procedures, fueling the expansion of the Technetium 99m market.
The market is further influenced by advancements in diagnostic technologies such as single-photon emission computed tomography (SPECT) and hybrid imaging systems, which enhance the precision of Tc-99m-based scans. Additionally, the increasing adoption of molecular imaging to enable early and accurate diagnosis supports steady market growth. Hospitals and diagnostic centers are increasingly relying on Tc-99m tracers due to their proven safety profile,…